ArticleFrontiers in pediatrics2021

Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1.

Benedetta Chiodini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.